Quantitative assessment of hand disability by the Nine-Hole-Peg test (9-HPT) in cervical spondylotic myelopathy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 8, 2008, Pages 965-967

  Olindo, Stephane ^a   Signate, A ^a   Richech, A ^a   Cabre, P ^a   Catonne, Y ^b   Smadja, D ^a   Pascal Mousselard, H ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CERVICAL SPONDYLOSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GAIT; HUMAN; LETTER; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SPINAL CORD DISEASE; ADOLESCENT; CERVICAL SPINE; DISABILITY; HAND; INNERVATION; MIDDLE AGED; MOTOR PERFORMANCE; PREDICTION AND FORECASTING; PSYCHOMOTOR DISORDER; REACTION TIME; REFERENCE VALUE; SPINAL CORD COMPRESSION; SPONDYLOSIS;

ADOLESCENT; ADULT; AGED; CERVICAL VERTEBRAE; DISABILITY EVALUATION; FEMALE; HAND; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; PSYCHOMOTOR DISORDERS; REACTION TIME; REFERENCE VALUES; SPINAL CORD COMPRESSION; SPINAL OSTEOPHYTOSIS;

EID: 48249156952     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.140285     Document Type: Letter

References (5)

1. Nurick S. The pathogenesis of the spinal cord disorder associated with cervical spondylosis. Brain 1972;95:87-100.
2. Chiles BW 3rd, Leonard MA, Choudhri HF, et al. Cervical spondylotic myelopathy: patterns of neurological deficit and recovery after anterior cervical decompression. Neurosurgery 1999;44:762-70.
3. Singh A, Crockard HA. Quantitative assessment of cervical spondylotic myelopathy by a simple walking test. Lancet 1999;354:370-3.
4. Mathiowetzs V, Weber G, Kashman N, et al. Adult's norms for 9-hole peg test of finger dexterity. Occup Ther J Res 1985;5:24-38.
5. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-82.